We expect the company to post Revenues/EBIDTA/PAT at a CAGR of 34%/43%/139% respectively over FY20-23E. We retain a BUY with a revised target price of Rs 908/share(earlier target Rs 877/share), valuing the company at 4x EV/EBIDTA FY23E, giving an upside of 21% from CMP.